Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.02 - $0.03 $295 - $443
14,771 Added 33.67%
58,644 $1,000
Q1 2024

May 15, 2024

SELL
$0.01 - $0.04 $20 - $82
-2,060 Reduced 4.48%
43,873 $0
Q4 2023

Feb 14, 2024

SELL
$0.01 - $0.25 $7 - $199
-797 Reduced 1.71%
45,933 $0
Q3 2023

Nov 14, 2023

BUY
$0.16 - $0.99 $1,705 - $10,551
10,658 Added 29.55%
46,730 $11,000
Q2 2023

Aug 14, 2023

BUY
$0.7 - $1.25 $3,580 - $6,393
5,115 Added 16.52%
36,072 $27,000
Q1 2023

May 15, 2023

BUY
$0.71 - $1.42 $7,392 - $14,785
10,412 Added 50.68%
30,957 $29,000
Q4 2022

Feb 14, 2023

BUY
$0.46 - $0.83 $9,450 - $17,052
20,545 New
20,545 $17,000

Others Institutions Holding BCDAW

# of Institutions
1
Shares Held
18.5K
Call Options Held
0
Put Options Held
0

About BIOCARDIA INC WT EXP 07/30/22


  • Ticker BCDAW
  • Sector Industrials
More about BCDAW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.